Related Experiment Video
Updated: Dec 18, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis
Konark Malhotra1, Aristeidis H Katsanos2, Nitin Goyal2
1From the Department of Neurology (K.M., A.T.), Allegheny Health Network, Pittsburgh, PA; Department of Neurology (A.H.K., A.W.A., A.V.A.), University of Ioannina School of Medicine, Greece; Department of Neurology (N.G., G.T.), University of Tennessee Health Science Center, Memphis; Department of Neurology and Stroke Center (H.G., G.M.D.M.), University Hospital Basel and University of Basel, Switzerland; Department of Neurology (P.D.M.), School of Medicine, University of Crete, Greece; Department of Cardiology (E.B.), Oslo University Hospital, Norway; and Second Department of Neurology (G.T.), National & Kapodistrian University of Athens, "Attikon" University Hospital, Greece. konark.malhotra@yahoo.com.
Insights
Chronic kidney disease (CKD) increases risks of intracranial hemorrhage (ICH) and adverse outcomes in acute ischemic stroke (AIS) patients receiving IV thrombolysis (IVT). Moderate to severe CKD is linked to higher ICH rates and poorer functional recovery post-IVT.
Area of Science:
- Nephrology
- Neurology
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) affects stroke outcomes.
- Intravenous thrombolysis (IVT) is a critical treatment for acute ischemic stroke (AIS).
- The impact of CKD on IVT safety and efficacy in AIS patients requires clarification.
Purpose of the Study:
- To determine the association between CKD and the safety and efficacy of IVT in AIS patients.
- To evaluate risks of intracranial hemorrhage (ICH) and mortality.
- To assess functional outcomes following IVT in AIS patients with CKD.
Main Methods:
- Systematic review and pairwise meta-analysis of 20 studies.
- Included 60,486 patients with AIS treated with IVT.
- Defined CKD by estimated glomerular filtration rate (eGFR) and analyzed outcomes like symptomatic ICH (sICH), any ICH, mortality, and functional outcomes (FFO, FI).
Main Results:
- CKD was associated with increased risks of sICH and any ICH in AIS patients treated with IVT.
- Adjusted analyses showed CKD linked to higher rates of sICH, any ICH, in-hospital mortality, and worse 3-month functional outcomes.
- CKD was associated with reduced 3-month favorable functional outcome (FFO) and functional independence (FI).
Conclusions:
- Moderate to severe CKD is associated with increased risks of intracranial hemorrhage (ICH) after IVT for AIS.
- CKD is linked to worse functional outcomes in AIS patients treated with IVT.
- These findings highlight the importance of considering CKD when managing AIS patients undergoing IVT.
Objective:
To determine the association of chronic kidney disease (CKD) with the safety and efficacy of IV thrombolysis (IVT) among patients with acute ischemic stroke (AIS).
Methods:
A systematic review and pairwise meta-analysis of studies involving patients with CKD undergoing IVT for AIS were conducted to evaluate the following outcomes: symptomatic intracranial hemorrhage (sICH), asymptomatic and any intracranial hemorrhage (ICH), in-hospital and 3-month mortality, 3-month favorable functional outcome (FFO; modified Rankin Scale [mRS] score 0-1), and 3-month functional independence (FI, mRS score 0-2). CKD was defined with estimated glomerular filtration rate (eGFR) ranging from mild (eGFR 60-89 mL/min) to moderate (eGFR 30-59 mL/min) to severe (eGFR 15-29 mL/min).
Results:
We identified 20 studies comprising 60,486 patients with AIS treated with IVT. In unadjusted analyses, CKD was associated with sICH according to the National Institute of Neurological Disorders and Stroke (NINDS) (7 studies; odds ratio [OR] 1.41, 95% confidence interval [CI] 1.19-1.67) and European Cooperative Acute Stroke Study (ECASS) II (9 studies; OR 1.37, 95% CI 1.01-1.85) definitions, any ICH (8 studies; OR 1.42, 95% CI 1.18-1.70), 3-month mortality (9 studies; OR 2.20, 95% CI 1.72-2.81), 3-month FFO (8 studies; OR 0.58, 95% CI 0.47-0.72), and 3-month FI (8 studies; OR 0.57, 95% CI 0.46-0.71). In adjusted analyses, CKD was associated with sICH according to NINDS (4 studies; ORadj 1.34, 95% CI 1.01-1.79) and ECASS II (3 studies; ORadj 2.08, 95% CI 1.27-3.43) definitions, any ICH (6 studies; ORadj 1.41, 95% CI 1.01-1.97), in-hospital mortality (2 studies; ORadj 1.19, 95% CI 1.09-1.30), and 3-month FFO (6 studies; ORadj 0.80, 95% CI 0.70-0.92).
Conclusions:
After adjustment for confounders in this pairwise meta-analysis, moderate to severe CKD is associated with increased risks of ICH and worse functional outcomes among patients with AIS treated with IVT.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction

